GlobalData’s report assesses the drugs in the Alpha Synuclein pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

Tel Aviv University-led team uses super-resolution microscopy to detect abnormal aggregates in skin cells, focusing on 2 gene ...

A new breakthrough in early detection for Parkinson’s disease could revolutionize how the disease is diagnosed and treated, ...

Genetic studies have strongly established a prominent role of α-synuclein (α- syn) missense and multiplication mutations in causing Parkinson's disease (PD). In neurons, α-syn is almost ...

The NIH has found evidence of research misconduct against Eliezer Masliah, M.D., the longtime head of the National Institute ...

Amprion was awarded a $100,000 research grant to support studies on the causes of sporadic ALS that could improve diagnosis ...

A neuronal protein called alpha-synuclein is the culprit in Parkinson’s disease, and a diagnosis is typically confirmed by the discovery of alpha-synuclein pathology in the post-mortem brain.

Studies show repeated brain trauma is linked to an increased risk of developing neurodegenerative disorders, including ...

Although inroads have been made in understanding the causes of the condition, a complete picture of how and why people ...

From biochemist to executive supplier to angel investor to company founder and CEO, Maria Maccecchini, Ph.D.’s ...